Q3682030 (Q3682030): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: importing one item from France) |
||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Kohesio project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / financed by | |||||||||||||||
| Property / financed by: European Union / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / country | |||||||||||||||
| Property / country: France / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
419,424.0 Euro
| |||||||||||||||
| Property / budget: 419,424.0 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
89,537.0 Euro
| |||||||||||||||
| Property / EU contribution: 89,537.0 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
21.35 percent
| |||||||||||||||
| Property / co-financing rate: 21.35 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
1 January 2017
| |||||||||||||||
| Property / start time: 1 January 2017 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / end time | |||||||||||||||
31 December 2018
| |||||||||||||||
| Property / end time: 31 December 2018 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
Centre National de la Recherche Scientifique | |||||||||||||||
| Property / beneficiary name (string): Centre National de la Recherche Scientifique / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary | |||||||||||||||
Le projet "Traitement des lymphomes folliculaires par des anticorps anti-CD20" a pour objectif le développement d'outils d'imagerie quantitative pour l'évaluation d'efficacité par microscopie à feuille de lumière. (French) | |||||||||||||||
| Property / summary: Le projet "Traitement des lymphomes folliculaires par des anticorps anti-CD20" a pour objectif le développement d'outils d'imagerie quantitative pour l'évaluation d'efficacité par microscopie à feuille de lumière. (French) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / fund | |||||||||||||||
| Property / fund: European Regional Development Fund / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / programme | |||||||||||||||
| Property / programme: Midi-Pyrénées et Garonne - ERDF/ESF/YEI / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 15:18, 17 November 2021
Project Q3682030 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3682030 in France |
Statements
89,537.0 Euro
0 references
419,424.0 Euro
0 references
21.35 percent
0 references
1 January 2017
0 references
31 December 2018
0 references
Centre National de la Recherche Scientifique
0 references
Le projet "Traitement des lymphomes folliculaires par des anticorps anti-CD20" a pour objectif le développement d'outils d'imagerie quantitative pour l'évaluation d'efficacité par microscopie à feuille de lumière. (French)
0 references
Identifiers
MP0008755
0 references